FOI.17536
Agency spend
FOI.17487
Mental Health (MH) agency use
FOI.17425
Theatres
FOI.17381
Ketamine attendances
FOI.17438
Insomnia treatments
FOI.17520
Biologic medicines in gastroenterology
FOI.17474
Dermatology and respiratory medicine
FOI.17416
Prescribing quality scheme/prescribing incentive scheme
FOI.17373
Treatment of inflammatory diseases
FOI.17364
Decontamination
FOI.17466
Agency spend
FOI.17351
Insourcing usage
FOI.17339
Artificial Intelligence (AI) and digital systems
FOI.17380
Temporary agency staffing
FOI.17350
Medications
FOI.17495
Workforce systems
FOI.17442
Technologies
FOI.17320
Homecare services
FOI.17366
Robotic surgery
FOI.17383
Operations